Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/25/24 16:05 | 11/21/24 | RCKT | Health | Drug | Pharmaceutical Preparations | Militello John | NJ | O | See Rema | 14 | S.d | -642 | 25.88 | 0 | -25 | 55 | D | |||||||||||||||
11/25/24 16:05 | 11/21/24 | RCKT | Health | Drug | Pharmaceutical Preparations | Patel Kinnari | NJ | O | See Rema | 5 | S.d | -465 | 21.83 | 0 | -21 | 512 | D | |||||||||||||||
11/25/24 16:05 | 11/21/24 | RCKT | Health | Drug | Pharmaceutical Preparations | Shah Gaurav | NJ | DO | CEO | 5 | S.d | -1,231 | 22.14 | 0 | -56 | 1,134 | D | |||||||||||||||
11/25/24 16:05 | 11/21/24 | RCKT | Health | Drug | Pharmaceutical Preparations | Wilson Martin | NJ | O | GC | 5 | S.d | -286 | 26.16 | 0 | -11 | 66 | D | |||||||||||||||
11/4/24 16:06 | 10/31/24 | RCKT | Health | Drug | Pharmaceutical Preparations | White Mark Andrew | NJ | O | See Rema | 3 | S | -422 | 22.62 | 0 | -19 | 75 | D | |||||||||||||||
6/10/24 10:34 | 3/21/24 | RCKT | Health | Drug | Pharmaceutical Preparations | Makker Gotham | NJ | D | 4 | S.m | -16,348 | 28.04 | 0 | -583 | 1,316 | I | ||||||||||||||||
4/16/24 17:45 | 4/12/24 | RCKT | Health | Drug | Pharmaceutical Preparations | Southwell David P | NJ | D | 1 | S.dm | -1,946 | 24.32 | 0 | -80 | 115 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |